<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03437018</url>
  </required_header>
  <id_info>
    <org_study_id>ID RCB 2017-A02329-44</org_study_id>
    <nct_id>NCT03437018</nct_id>
  </id_info>
  <brief_title>MONITORING OF MODERATE DIABETIC RETINOPATHY BY TELE-EXPERTISE</brief_title>
  <acronym>TELERETINO</acronym>
  <official_title>COMPARISON OF MONITORING OF MODERATE DIABETIC RETINOPATHY BY TELE-EXPERTISE AND CONVENTIONAL OPHTHALMOLOGICAL CONSULTATION</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Sud Francilien</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Sud Francilien</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the monitoring of moderate diabetic retinopathy by
      tele-expertise
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study compares 2 strategies of monitoring of moderate diabetic retinopathy (RD).After a
      consultation with an orthoptist for measurement of visual acuity, measurement of ocular tone
      by pulsed air tonometer, retinography pictures (9 photographs: one of the posterior pole and
      8 of the retinal periphery) and Optical Coherence Tomography (OCT), results are evaluated
      on-site by an ophthalmologist and then sent through a secure medical online application to an
      ophthalmologist expert in RD for assessment. Each patient is his own control.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>classification of diabetic retinopathy (DR)</measure>
    <time_frame>1 month</time_frame>
    <description>DR is classified in 3 stages : moderate non proliferative DR, severe non proliferative DR, and proliferative DR</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>classification of macular edema</measure>
    <time_frame>1 month</time_frame>
    <description>macular edema (ME) is classified in 4 stages : no ME , mild ME, moderate ME, severe ME</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>follow-up strategy</measure>
    <time_frame>1 month</time_frame>
    <description>follow-up strategy can take to ways : no treatment required and continuation of the monitoring/ complementary exam or treatment required</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>medical time necessary for examination and analyse</measure>
    <time_frame>1 month</time_frame>
    <description>time necessary for direct examination and analyse by ophthalmologist on-site and time necessary for remote analyse are measured</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>moderate diabetic retinopathy follow-up by tele-expertise</intervention_name>
    <description>Consultation by an orthoptist to measure visual acuity, eye tone by pulsed air tonometer, and retinography images after pupillary dilatation (9 photographs: one of the posterior pole and 8 of the peripheral retina) and optical coherence tomography (OCT).
The results are immediately evaluated on site by an ophthalmologist. The results are sent through a secure online medical application to a diabetic retinopathy specialist ophthalmologist for evaluation.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patient with complicated diabetes mellitus with moderate retinopathy requiring periodic
        follow-up by an ophthalmologist
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient with complicated diabetes mellitus with moderate retinopathy

        Exclusion Criteria:

          -  Patient deprived of liberty by judicial or administrative decision

          -  Person subject to a legal protection measure

          -  Patient already involved in another clinical trial protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfred Penfornis</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Sud Francilien</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>François-Xavier Laborne</last_name>
    <phone>+33169139597</phone>
    <email>fx.laborne@samu91.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dalia Mignot</last_name>
    <phone>+33161693730</phone>
    <email>dalia.mignot@chsf.fr</email>
  </overall_contact_backup>
  <reference>
    <citation>Schulze-Döbold C, Erginay A, Robert N, Chabouis A, Massin P. Ophdiat(®): five-year experience of a telemedical screening programme for diabetic retinopathy in Paris and the surrounding area. Diabetes Metab. 2012 Nov;38(5):450-7. doi: 10.1016/j.diabet.2012.05.003. Epub 2012 Jul 4.</citation>
    <PMID>22765981</PMID>
  </reference>
  <reference>
    <citation>Chabouis A, Berdugo M, Meas T, Erginay A, Laloi-Michelin M, Jouis V, Guillausseau PJ, M'bemba J, Chaine G, Slama G, Cohen R, Reach G, Marre M, Chanson P, Vicaut E, Massin P. Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres. Diabetes Metab. 2009 Jun;35(3):228-32. doi: 10.1016/j.diabet.2008.12.001. Epub 2009 Apr 5.</citation>
    <PMID>19349202</PMID>
  </reference>
  <reference>
    <citation>Erginay A, Chabouis A, Viens-Bitker C, Robert N, Lecleire-Collet A, Massin P. OPHDIAT: quality-assurance programme plan and performance of the network. Diabetes Metab. 2008 Jun;34(3):235-42. doi: 10.1016/j.diabet.2008.01.004.</citation>
    <PMID>18424210</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2018</study_first_submitted>
  <study_first_submitted_qc>February 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2018</study_first_posted>
  <last_update_submitted>February 12, 2018</last_update_submitted>
  <last_update_submitted_qc>February 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>moderate diabetic retinopathy</keyword>
  <keyword>tele-expertise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

